GARFIELD-VTE explored acute and long-term management and outcomes in patients with symptomatic DVTs and PEs treated in a real-world setting with standard therapy and new oral anticoagulants (OACs)
Recruitment – complete
Total Patients Enrolled – 10,878
GARFIELD-VTE explored acute and long-term management and outcomes in patients with symptomatic DVT and PEs treated in a real world setting with standard therapy and new oral anticoagulants (OACs). It provided patients, physicians and policy makers with unprecedented insights on managing and improvement patient care. For patients with DVT and PE, fast action in the acute phase of treatment, especially rapidly fatal PEs, is vital for preserving life and health. Equally important, the risk of recurrence needs to also be managed. Current treatment regimens in real-life practice seem to be shorter than recommended guidelines. Real – world clinical data is needed to confirm this dynamic and understand why it occurs. The GARFIELD registry was an academic research initiative, led by the TRI and a multi-disciplinary steering committee – and it was supported by an unrestricted research grant from Bayer AG. The Global Anticoagulant Registry in the field of venous thromboembolism events was a perspective, multicentre, international registry of patients with newly diagnosed VTE: Deep Vein Thrombosis (DVT) and / or Pulmonary Embolism (PE). The GARFIELD-VTE registry brings a real-world perspective to the field of venous thrombosis.
Scroll over the window below to view our timeline
GARFIELD-VTE is important in bridging the gap between research and clinical practice, serving to increase awareness of the importance of DVT / PE and its treatment.
The objectives are:
Audit requirements
Patient Eligibility
Inclusion criteria
Exclusion criteria
Over the duration of the registry GARFIELD-VTE will:
Obtain clarity on:
Additional outcomes include:
GARFIELD-VTE is governed by the highest academic and ethical standards in the generation, dissemination and communication of its research findings.
Audit Requirements:
Coming soon… If you would like to be notified of when this is available click here and add your details to receive updates
